- Home
- IVA vs TAVI Comparison
IVA vs TAVI Comparison
Compare IVA & TAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- TAVI
- Stock Information
- Founded
- IVA 2011
- TAVI 2024
- Country
- IVA France
- TAVI United Kingdom
- Employees
- IVA N/A
- TAVI N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- TAVI
- Sector
- IVA Health Care
- TAVI
- Exchange
- IVA Nasdaq
- TAVI Nasdaq
- Market Cap
- IVA 162.8M
- TAVI 159.4M
- IPO Year
- IVA 2020
- TAVI 2024
- Fundamental
- Price
- IVA $2.94
- TAVI $10.06
- Analyst Decision
- IVA Strong Buy
- TAVI
- Analyst Count
- IVA 4
- TAVI 0
- Target Price
- IVA $13.25
- TAVI N/A
- AVG Volume (30 Days)
- IVA 7.6K
- TAVI 60.4K
- Earning Date
- IVA 03-26-2025
- TAVI 01-01-0001
- Dividend Yield
- IVA N/A
- TAVI N/A
- EPS Growth
- IVA N/A
- TAVI N/A
- EPS
- IVA N/A
- TAVI N/A
- Revenue
- IVA $15,243,814.00
- TAVI N/A
- Revenue This Year
- IVA $18.05
- TAVI N/A
- Revenue Next Year
- IVA $46.74
- TAVI N/A
- P/E Ratio
- IVA N/A
- TAVI $1,944.25
- Revenue Growth
- IVA N/A
- TAVI N/A
- 52 Week Low
- IVA $1.53
- TAVI $9.89
- 52 Week High
- IVA $3.98
- TAVI $10.35
- Technical
- Relative Strength Index (RSI)
- IVA 52.48
- TAVI N/A
- Support Level
- IVA $2.88
- TAVI N/A
- Resistance Level
- IVA $3.10
- TAVI N/A
- Average True Range (ATR)
- IVA 0.18
- TAVI 0.00
- MACD
- IVA -0.02
- TAVI 0.00
- Stochastic Oscillator
- IVA 54.55
- TAVI 0.00
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About TAVI Tavia Acquisition Corp. Ordinary Shares
Tavia Acquisition Corp is a blank check company.